News

ATIR is under development to prevent life-threatening graft versus host disease (GvHD), a major complication of allogeneic bone marrow transplantations. By preventing the occurrence of GvHD, ATIR enables

Genizon’s study identified multiple genes associated with the disease using DNA samples from patients from the Quebec founder population. Michel Maziade, professor of psychiatry at the University of

Siemens says it can now can offer its customers a comprehensive healthcare solutions’ portfolio, which brings together the entire medical imaging, laboratory diagnostics and clinical information technology (IT)

The award is the final phase of an aggregate of $4.3 million of grant support from the National Institute of Neurological Disorders and Stroke (NINDS), a division of

Under the amended protocol, the primary endpoint for the 160-patient, historically controlled, multi-center Phase III study would change from survival at 100 days to complete response as defined

The court sustained two other patents, directed to a specific manufacturing process and to food products that include omega-3 fatty acids (DHA). The ruling clears the way for

The closure, which is expected to be completed by the end of December, will result in the loss of four R&D jobs and will contribute approximately E1.5 million

The patent will serve to enhance protection of the intellectual property underlying the company’s Promet treatment program for cocaine dependence, and follows the granting of cocaine patents in

The double-blind, parallel, 12-week study with seven treatment arms in almost 1400 patients evaluated 1g of Cordaptive (1g extended-release niacin/20mg laropiprant) co-administered with simvastatin 10mg to 40mg in